| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Meeting Report |
Departments of 1 Clinical Cancer Prevention and 2 Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center; 3 Breast Center, Baylor College of Medicine, Houston, Texas; 4 National Cancer Institute, Bethesda, Maryland; and 5 American Cancer Society, Atlanta, Georgia
Requests for reprints: Scott M. Lippman, Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009. Phone: 713-745-5439; Fax: 713-745-2012; E-mail: slippman{at}mdanderson.org.
Addressing genetics, risk modeling, molecular targets for chemoprevention, clinical prevention trials, behavioral prevention research, public policy, and more, the Fifth Annual International Conference on Frontiers in Cancer Prevention Research, held in Boston, Massachusetts, in November 2006, added an outstanding new chapter to the landmark AACR Frontiers program for advancing the science and practice of cancer prevention throughout the world. [Cancer Res 2007;67(19):8989–93]
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |